(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

NOVOS SAIS DE N,N-DIMETILTRIPTAMINA E FORMAS DE SAL CRISTALINO

Em AnáliseInvention PatentPCT · US2022030912
Talk to an expert

Application data

Invention Patent NOVOS SAIS DE N,N-DIMETILTRIPTAMINA E FORMAS DE SAL CRISTALINO de ATAI THERAPEUTICS, INC. — IPC C07D 209/16
Invention Patent NOVOS SAIS DE N,N-DIMETILTRIPTAMINA E FORMAS DE SAL CRISTALINO de ATAI THERAPEUTICS, INC. — IPC C07D 209/16. Drawing published by the INPI in the Industrial Property Gazette.

Number

112023024550

Type

Invention Patent

Filing

05/25/2022

Publication

02/06/2024

PCT

US2022030912
View on INPI

Progress at the INPI

  1. Filing05/25/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 05/25/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 02/06/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ATAI THERAPEUTICS, INC.

US

Inventors

F. M. (pessoa física)

US

K. S. (pessoa física)

US

M. N. (pessoa física)

CA

Technical data

IPC Classification

C07D 209/16

Priority claims

US

63/192,938 · 05/25/2021

Abstract

NOVOS SAIS DE N,N-DIMETILTRIPTAMINA E FORMAS DE SAL CRISTALINO. Esta divulgação fornece sais de N,N-dimetiltriptamina e formas cristalinas de sal, sua preparação, composições farmacêuticas compreendendo os referidos sais e formas cristalinas de sal e sua utilização no tratamento de doenças e condições neurológicas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

02/06/2024

RPI 2770

Alteração de dados cadastrais

#1.1

12/05/2023

RPI 2761

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.